Benzinga | Sep 9, 2021 08:09AM EDT

Stephens & Co. Initiates Coverage On Apollo Endosurgery with Overweight Rating, Announces Price Target of $15

Stephens & Co. analyst Chris Cooley initiates coverage on Apollo Endosurgery (NASDAQ:APEN) with a Overweight rating and announces Price Target of $15.